Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: A Gynecologic Oncology Group study
- 1 March 1993
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 168 (3) , 805-807
- https://doi.org/10.1016/s0002-9378(12)90824-8
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Phase II trial of ifosfamide and mesna in leiomyosarcoma ofthe uterus: A Gynecologic Oncology Group studyAmerican Journal of Obstetrics and Gynecology, 1992
- Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC studyCancer Chemotherapy and Pharmacology, 1990
- Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989
- Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervixInvestigational New Drugs, 1989
- Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)American Journal of Obstetrics and Gynecology, 1989
- A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervixCancer Chemotherapy and Pharmacology, 1986